Literature DB >> 26618464

Retro or PeriBulbar Injection Techniques to Reverse Visual Loss After Filler Injections.

Jean Carruthers1, Steven Fagien, Peter Dolman.   

Abstract

BACKGROUND: With the increasing popularity of three dimensional filler treatments, the tip of the injecting needle or cannula is subdermal, often adjacent to the facial vasculature. Inadvertent canalization of these vessels can rarely result in vascular occlusion with consequent blindness or stroke.
OBJECTIVE: The goal was to demonstrate a technique of retro or peribulbar injection of hyaluronidase should such an emergency arise if no ophthalmologist was immediately available. The treatment is needed urgently because the retina can only withstand up to 90 minutes of hypoxia.
MATERIALS AND METHODS: We present verbal and diagrammatic instructions for this treatment and videos of both the retrobulbar technique (courtesy of Dr. D. Maberley) and peribulbar technique (courtesy of Dr. S. Fagien).
RESULTS: None of us have yet used this technique to treat iatrogenic filler induced blindness but we present the information for the benefit of patient safety, given the limited time the retina can survive vascular occlusion.
CONCLUSION: Inadvertent canalization of facial vessels can cause embolic occlusion of retinal vasculature because of the anastomotic nature of the facial vasculature and the end artery morphology of the retinal circulation. Embolism from 3-dimensional hyaluronic acid filler use is potentially reversible if hyaluronidase is injected into the adjacent tissue.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26618464     DOI: 10.1097/DSS.0000000000000558

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  8 in total

Review 1.  [Responsible application of hyaluronic acid fillers in aesthetic medicine : Prevention, diagnosis and therapy of adverse events and complications].

Authors:  Wolfgang G Philipp-Dormston
Journal:  Hautarzt       Date:  2021-04-20       Impact factor: 0.751

2.  [Hyaluronic acid fillers in dermatology].

Authors:  Wolfgang G Philipp-Dormston
Journal:  Hautarzt       Date:  2018-06       Impact factor: 0.751

3.  [Sudden loss of vision after cosmetic face treatment].

Authors:  F N Auerbach; R Khoramnia; G U Auffarth; J A Carmona Hernandez; T Tandogan; D Kaiser; S Hähnel; S Sel
Journal:  Ophthalmologe       Date:  2018-07       Impact factor: 1.059

4.  Effectiveness of Low Doses of Hyaluronidase to Remove Hyaluronic Acid Filler Nodules: A Randomized Clinical Trial.

Authors:  Murad Alam; Rosemara Hughart; Amelia Geisler; Kapila Paghdal; Amanda Maisel; Alexandra Weil; Dennis P West; Emir Veledar; Emily Poon
Journal:  JAMA Dermatol       Date:  2018-07-01       Impact factor: 10.282

Review 5.  A Review of the Emerging Role of Silk for the Treatment of the Eye.

Authors:  Simon H Tran; Clive G Wilson; F Philipp Seib
Journal:  Pharm Res       Date:  2018-11-05       Impact factor: 4.200

6.  Complication Management following Rejuvenation Procedures with Hyaluronic Acid Fillers-an Algorithm-based Approach.

Authors:  Philippe Snozzi; Jani A J van Loghem
Journal:  Plast Reconstr Surg Glob Open       Date:  2018-12-17

7.  A Consensus on Minimizing the Risk of Hyaluronic Acid Embolic Visual Loss and Suggestions for Immediate Bedside Management.

Authors:  Greg J Goodman; Mark R Magnusson; Peter Callan; Stefania Roberts; Sarah Hart; Cara B McDonald; Michael Clague; Alice Rudd; Philip S Bekhor; Steven Liew; Michael Molton; Katy Wallace; Niamh Corduff; Sean Arendse; Shobhan Manoharan; Ava Shamban; Izolda Heydenrych; Ashish C Bhatia; Peter Peng; Tatjana Pavicic; Krishan Mohan Kapoor; David E Kosenko
Journal:  Aesthet Surg J       Date:  2020-08-14       Impact factor: 4.283

8.  Orbital infarction syndrome following hyaluronic acid filler rhinoplasty.

Authors:  Luai Eldweik
Journal:  Am J Ophthalmol Case Rep       Date:  2021-03-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.